GW&K Investment Management’s BioCryst Pharmaceuticals BCRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$30.9M	Buy	3,240,462 +79,538	+3%	+$618K	0.27%	137
2025 Q4	$24.7M	Buy	3,160,924 +963,159	+44%	+$6.96M	0.21%	179
2025 Q3	$16.7M	Sell	2,197,765 -425,772	-16%	-$3.55M	0.15%	223
2025 Q2	$23.5M	Sell	2,623,537 -261,143	-9%	-$2.43M	0.21%	180
2025 Q1	$21.6M	Sell	2,884,680 -56,716	-2%	-$457K	0.2%	190
2024 Q4	$22.1M	Sell	2,941,396 -336,204	-10%	-$2.55M	0.19%	194
2024 Q3	$24.9M	Sell	3,277,600 -127,100	-4%	-$966K	0.21%	186
2024 Q2	$21M	Sell	3,404,700 -49,208	-1%	-$272K	0.19%	190
2024 Q1	$17.5M	Buy	3,453,908 +1,116,225	+48%	+$6.28M	0.15%	205
2023 Q4	$14M	Sell	2,337,683 -233,180	-9%	-$1.35M	0.13%	214
2023 Q3	$18.2M	Sell	2,570,863 -27,379	-1%	-$197K	0.18%	188
2023 Q2	$18.3M	Sell	2,598,242 -5,689	-0.2%	-$45.7K	0.17%	191
2023 Q1	$21.7M	Buy	2,603,931 +876,844	+51%	+$8.44M	0.21%	169
2022 Q4	$19.8M	Buy	1,727,087 +309,947	+22%	+$3.87M	0.2%	178
2022 Q3	$17.9M	Buy	+1,417,140	New	+$18.2M	0.2%	177